Streck Joanna M, Regan Susan, Chang Yuchiao, Kelley Jennifer H K, Singer Daniel E, Rigotti Nancy A
Department of Psychological Science, Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.
Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, MA, USA; Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Drug Alcohol Depend. 2017 Sep 1;178:586-592. doi: 10.1016/j.drugalcdep.2017.06.005. Epub 2017 Jul 8.
Individuals with substance use disorders (SUD) smoke at higher rates and have higher tobacco-related mortality than the general population. Despite having an interest in smoking cessation, smokers with SUDs may have greater difficulty quitting.
Analysis of data from a RCT testing a post-discharge smoking cessation intervention for hospitalized cigarette smokers interested in quitting. Past 7day tobacco abstinence was self-reported at 1, 3, and 6 months and biochemically confirmed at 6 months post-discharge. Other drug use was assessed at baseline by self-report or a past-year discharge diagnosis of SUD. Multiple logistic regression compared tobacco cessation outcomes among participants with no recreational drug use (NDU; n=942) vs. marijuana only (MU; n=284) vs. other illicit drugs (IDU; n=131).
Groups differed at baseline on age, gender, race, education, other household smokers, alcohol use, and anxiety/depression (all p<0.05). Confirmed 6-month tobacco abstinence was lower among IDU than NDU participants (9% vs 18%, p=0.01; AOR=0.43, CI: 0.22-0.84) after adjustment for study arm, smoking characteristics, demographics, quality of life, alcohol use and MU. Confirmed 6-month abstinence did not differ significantly between MU vs. NDU participants (14% vs 18%, p>0.05; AOR=0.77, CI:0.51-1.14). Counseling and medication use did not differ significantly among groups at any follow-up.
Hospitalized smokers who planned to stop smoking after discharge and used cessation assistance were less successful if they had used illicit drugs in the past year, but not if they had only used marijuana. More intensive or tailored interventions may be required to address smoking in this population.
患有物质使用障碍(SUD)的个体吸烟率更高,与烟草相关的死亡率也高于普通人群。尽管有戒烟意愿,但患有SUD的吸烟者可能更难戒烟。
对一项随机对照试验(RCT)的数据进行分析,该试验针对有戒烟意愿的住院吸烟者进行出院后戒烟干预。在出院后1个月、3个月和6个月时,通过自我报告过去7天的烟草戒断情况,并在出院后6个月进行生化确认。在基线时,通过自我报告或过去一年的SUD出院诊断评估其他药物使用情况。多因素逻辑回归比较了无娱乐性药物使用(NDU;n = 942)、仅使用大麻(MU;n = 284)和使用其他非法药物(IDU;n = 131)的参与者的戒烟结果。
各小组在基线时的年龄、性别、种族、教育程度、其他家庭吸烟者、酒精使用情况以及焦虑/抑郁程度存在差异(均p < 0.05)。在对研究分组、吸烟特征、人口统计学、生活质量、酒精使用情况和MU进行调整后,IDU参与者中6个月经确认的烟草戒断率低于NDU参与者(9%对18%,p = 0.01;调整后比值比[AOR]=0.43,置信区间[CI]:0.22 - 0.84)。MU与NDU参与者之间6个月经确认的戒断率无显著差异(14%对18%,p > 0.05;AOR = 0.77,CI:0.51 - 1.14)。在任何随访中,各小组的咨询和药物使用情况均无显著差异。
出院后计划戒烟并接受戒烟辅助的住院吸烟者,如果在过去一年中使用过非法药物,则戒烟成功率较低,但仅使用过大麻的吸烟者则不然。可能需要更强化或更具针对性的干预措施来解决该人群的吸烟问题。